These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 11715950

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [Abstract] [Full Text] [Related]

  • 5. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW, Li D, McQuone SJ, Ralston R.
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [Abstract] [Full Text] [Related]

  • 6. The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer.
    Chang JY, Xia W, Shao R, Sorgi F, Hortobagyi GN, Huang L, Hung MC.
    Oncogene; 1997 Feb 06; 14(5):561-8. PubMed ID: 9053854
    [Abstract] [Full Text] [Related]

  • 7. Safety studies of the intraperitoneal injection of E1A--liposome complex in mice.
    Xing X, Liu V, Xia W, Stephens LC, Huang L, Lopez-Berestein G, Hung MC.
    Gene Ther; 1997 Mar 06; 4(3):238-43. PubMed ID: 9135737
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Liposome-mediated in vivo E1A gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER-2/neu.
    Yu D, Matin A, Xia W, Sorgi F, Huang L, Hung MC.
    Oncogene; 1995 Oct 05; 11(7):1383-8. PubMed ID: 7478560
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Systemic gene therapy in human xenograft tumor models by liposomal delivery of the E1A gene.
    Ueno NT, Bartholomeusz C, Xia W, Anklesaria P, Bruckheimer EM, Mebel E, Paul R, Li S, Yo GH, Huang L, Hung MC.
    Cancer Res; 2002 Nov 15; 62(22):6712-6. PubMed ID: 12438271
    [Abstract] [Full Text] [Related]

  • 13. E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway.
    Ueno NT, Bartholomeusz C, Herrmann JL, Estrov Z, Shao R, Andreeff M, Price J, Paul RW, Anklesaria P, Yu D, Hung MC.
    Clin Cancer Res; 2000 Jan 15; 6(1):250-9. PubMed ID: 10656456
    [Abstract] [Full Text] [Related]

  • 14. Lessons learned from independent central review.
    Ford R, Schwartz L, Dancey J, Dodd LE, Eisenhauer EA, Gwyther S, Rubinstein L, Sargent D, Shankar L, Therasse P, Verweij J.
    Eur J Cancer; 2009 Jan 15; 45(2):268-74. PubMed ID: 19101138
    [Abstract] [Full Text] [Related]

  • 15. A phase I/II dose escalation and activity study of intravenous injections of OCaP1 for subjects with refractory osteosarcoma metastatic to lung.
    Benjamin R, Helman L, Meyers P, Reaman G.
    Hum Gene Ther; 2001 Aug 10; 12(12):1591-3. PubMed ID: 11529247
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of intratracheal lung cancer development by systemic delivery of E1A.
    Chang JY, Xia W, Shao R, Hung MC.
    Oncogene; 1996 Oct 03; 13(7):1405-12. PubMed ID: 8875978
    [Abstract] [Full Text] [Related]

  • 17. Gene therapy for head and neck cancer.
    Gleich LL.
    Laryngoscope; 2000 May 03; 110(5 Pt 1):708-26. PubMed ID: 10807351
    [Abstract] [Full Text] [Related]

  • 18. A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001.
    Cunningham C, Nemunaitis J.
    Hum Gene Ther; 2001 Aug 10; 12(12):1594-6. PubMed ID: 11529249
    [Abstract] [Full Text] [Related]

  • 19. Issues in the development of gene therapy: preclinical experiments in E1A gene delivery.
    Ueno NT, Xia W, Tucker SD, Zhang S, Lopez-Berestein G, Huang L, Hung MC.
    Oncol Rep; 1999 Aug 10; 6(2):257-62. PubMed ID: 10022986
    [Abstract] [Full Text] [Related]

  • 20. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
    Akbulut H, Zhang L, Tang Y, Deisseroth A.
    Cancer Gene Ther; 2003 May 10; 10(5):388-95. PubMed ID: 12719708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.